The ADAM metallopeptidase domain 10 (ADAM10) gene was already identified as a biomarker for Alzheimer’s disease in humans, with functions related to the cleavage amyloid precursors that act during the inflammation process of senile plaques [54]. The gene discussed is ADAM10; the disease is Alzheimer disease.